drugset / Trial / NCT02150343

Phase II HDM-SPIRE Safety and Efficacy Study

NCT02150343 ↗

Phase 2 Completed 715 enrolled Circassia Limited Quintiles, Inc. · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to compare the treatment effect of three treatment regimens of HDM-SPIRE vs placebo and to evaluates the treatment effect of HDM-SPIRE on symptoms, rescue medication usage, Quality of Life and Sleep Quality

Timeline

Start
2014-09
Primary completion
2017-04-13
Completion
2017-04-13

Drugs

EvaluationDrugModalityDoseRoute
Subject HDM-SPIRE Unknown 12 unknown —
Subject HDM-SPIRE Unknown 20 unknown —

Indications